Anosmia: Clinical Trials

176 trials for Anosmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

90 completed, 31 unknown, 23 recruiting, 12 not yet recruiting. 66 Not applicable, 23 Phase 2, 14 Phase 4, 11 Phase 3, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable66Completed 31, Recruiting 11, Not yet recruiting 9, Unknown 9, Active not recruiting 2, Terminated 2, Withdrawn 2
Phase 223Completed 14, Unknown 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 414Completed 7, Unknown 5, Withdrawn 2
Phase 311Completed 6, Recruiting 2, Unknown 2, Terminated 1
Phase 17Completed 3, Terminated 2, Unknown 1, Withdrawn 1
Early Phase 14Unknown 2, Completed 1, Not yet recruiting 1

Follow this condition Literature Review of Anosmia trials Research Report on Anosmia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SniffTrain: Effectiveness of Sniff Training in the Treatment of Post-Viral Anosmia
Sniff Training Kits - Post-viral Anosmia, Anosmia
Not applicableNot yet recruitingUniversity of Virginia2042027-01-052026-10-05
In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy
CONVIVO system, Fluorescein injection, USP 10% - Endonasal Surgery, Endoscopic Sinus Surgery
Early Phase 1Not yet recruitingDartmouth-Hitchcock Medical Center362026-11-032026-10-20
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
RecruitingNational Institute on Drug Abuse (NIDA)1202026-10-262026-10-21
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)3502026-10-262026-10-21
Olfactory Transcranial Focused Ultrasound
transcranial focused ultrasound (tFUS) - Healthy, Olfaction
Not applicableRecruitingMedical University of South Carolina282026-10-012026-10-06
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Respiratory Tract Infection, Smell Disorder
RecruitingNational Institute on Deafness and Other Communication Disorders (NIDCD)802026-10-012026-10-09
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Smartwatch and phone app - Parkinson Disease (PD), REM Sleep Behavior Disorder (iRBD)
Not yet recruitingQueen Mary University of London602026-10-012026-10-02
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label
Trigeminal Nerve Stimulation-enhanced Smell Training - Olfactory Impairment
Phase 2RecruitingMedical University of South Carolina602026-07-102026-08-12
Effects of Olfactory Stimuli in Virtual Reality Cue Exposure on Craving and Attentional Bias in Alcohol Use Disorder
VR-CE - Alcohol Use Disorder
Not applicableNot yet recruitingCharite University, Berlin, Germany602026-07-012026-06-25
SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level
Pleasant Food Odor Stimulation, Control Environmental Condition - Obesity & Overweight, Insulin Resistance Syndrome
Not applicableNot yet recruitingHospices Civils de Lyon202026-06-012026-06-10
Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial
Slow-SPEED app - Hyposmia, Olfactory Dysfunction
Not applicableRecruitingQueen Mary University of London1102026-05-272026-06-29
PANDORA: Evaluation of Platelet-rich Plasma in Non-tumoural Odour Disorders: a Descriptive Pilot Study.
Autologous Platelet-Rich Plasma (PRP) Injection - Olfactory Dysfunction, Post-traumatic Olfactory Dysfunction
Not applicableNot yet recruitingHospices Civils de Lyon302026-05-012026-03-20
Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer
Oncology Dietitian's Standard of Care, Personalized Culinary and Nutrition Therapy - Cancer, Sarcopenia
Not applicableNot yet recruitingGali Perel2002026-04-012026-04-02
Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia
Intranasal PRP Plus Topical Insulin, Intranasal PRP Plus Saline (Placebo) - Anosmia, Inflammatory Anosmia
Not applicableNot yet recruitingAmin Javer202026-03-302026-02-03
Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence
VR Cue-Exposure Including Olfactory Stimuli - Alcohol Dependence
Not applicableCompletedCharite University, Berlin, Germany202026-03-072026-10-20
Comparing the Olfactory Perception of a Fragrance-Loaded SpECs Over Time
Fragrance - Perception, Self
Not applicableNot yet recruitingRoyal College of Surgeons in Ireland - Medical University of Bahrain102026-02-152026-02-05
Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae
Non invasive neuromodulation therapy, Manual therapy, Placebo with non invasive neuromodulation - Covid-19 Recurrent
Not applicableNot yet recruitingClinica Gema Leon1042026-01-012025-09-18
Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training
Smell Training - Smell Loss, Chronic Rhinosinusitis (CRS)
Not applicableRecruitingThe Cleveland Clinic522025-12-092026-07-02
Topical Versus Injection PRP for Olfactory Dysfunction
Intranasal Injection of Autologous PRP, Carrier-Assisted Topical Application of Autologous PRP, platelet-rich plasma - Olfactory Dysfunction, Anosmia
Phase 3RecruitingTaipei Veterans General Hospital, Taiwan602025-09-112026-10-05
Olfactory Training in Mild Cognitive Impairment
Olfactory Memory Training, Visual Memory Training - Mild Cognitive Impairment
Not applicableRecruitingJeffrey Motter302025-08-072026-09-04

Showing 20 of 176. Sign in to see all of them.

Narrower conditions

COVID-19 (57)  ·  Olfaction Disorders (37)  ·  Ageusia (12)  ·  Dysgeusia (9)  ·  Parkinson Disease (9)  ·  Taste Disorders (8)  ·  Alzheimer Disease (7)  ·  Cognitive Dysfunction (7)  ·  Post-Acute COVID-19 Syndrome (7)  ·  Obesity (6)  ·  Coronavirus Infections (5)  ·  Depression (5)  ·  Anxiety Disorders (4)  ·  Severe Acute Respiratory Syndrome (4)

Broader conditions

Pathological Conditions, Signs and Symptoms (176)  ·  Signs and Symptoms (176)  ·  Nervous System Diseases (175)  ·  Neurologic Manifestations (174)  ·  Sensation Disorders (174)  ·  Olfaction Disorders (139)  ·  Infections (66)  ·  Respiratory Tract Diseases (66)  ·  Lung Diseases (63)  ·  Virus Diseases (63)  ·  Coronaviridae Infections (62)  ·  Nidovirales Infections (62)  ·  RNA Virus Infections (62)  ·  Respiratory Tract Infections (62)  ·  Pneumonia (60)

Interventions

Olfactory Training (17)  ·  Oils, Volatile (3)  ·  Saline Solution (3)  ·  Sodium Chloride (3)  ·  Theophylline (3)  ·  Acetylcysteine (2)  ·  Adrenal Cortex Hormones (2)  ·  Budesonide (2)  ·  Donepezil (2)  ·  Insulin (2)  ·  Mepivacaine (2)  ·  Odorants (2)  ·  Prednisolone (2)  ·  Smell (2)  ·  Standard of Care (2)

Sponsors

Washington University School of Medicine (9)  ·  Hospices Civils de Lyon (4)  ·  Institut Pasteur (3)  ·  Johns Hopkins University (3)  ·  Massachusetts General Hospital (3)  ·  Medical University of South Carolina (3)  ·  AHS Cancer Control Alberta (2)  ·  Ain Shams University (2)  ·  Centre Hospitalier Universitaire de Nīmes (2)  ·  Charite University, Berlin, Germany (2)  ·  Duke University (2)  ·  Hospital Sultanah Bahiyah (2)  ·  Karolinska Institutet (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Michael J. Fox Foundation for Parkinson's Research (2)

Countries

United States (58)  ·  France (24)  ·  Egypt (10)  ·  Canada (9)  ·  United Kingdom (8)  ·  Italy (7)  ·  Germany (6)  ·  Belgium (5)  ·  Turkey (Türkiye) (5)  ·  China (4)  ·  Spain (4)  ·  Brazil (3)  ·  Israel (3)  ·  Norway (3)  ·  Saudi Arabia (3)

Top investigators

Jay F Piccirillo, MD (3)  ·  Benjamin Lallemant (2)  ·  Bradley Goldstein, MD, PhD (2)  ·  Davangere Devanand, M.D. (2)  ·  Mark W Albers, MD PhD (2)  ·  Siti Sabzah Mohd Hashim, MD MS (2)  ·  Stefan Gutwinski, Prof. Dr. med. (2)  ·  A KL Reyners, MD, PhD (1)  ·  Abdelhakim F Ghallab, MD (1)  ·  Abdelrahman A Abdelalim, MD (1)  ·  Alastair J Noyce, BMedSci, MBBS, MSc, MRCP, PhD (1)  ·  Alfred-Marc Iloreta, MD (1)

Results publications

PMID 36062970, PMID 36063364, PMID 10366002, PMID 10400452, PMID 15023839, PMID 15277925, PMID 15502041, PMID 16369168, PMID 17761724, PMID 18178322, PMID 18377764, PMID 18946287, PMID 19359985, PMID 20962652, PMID 21191261, PMID 22371929, PMID 22377744, PMID 23165381, PMID 23246491, PMID 23338615, PMID 23535829, PMID 23643382, PMID 23731850, PMID 23798331, PMID 23875929, PMID 23994303, PMID 24482154, PMID 25394172, PMID 25514489, PMID 26052727, PMID 26415766, PMID 26888712, PMID 27833669, PMID 27923495, PMID 28877891, PMID 29557250, PMID 30116207, PMID 30166653, PMID 30657649, PMID 32027340, PMID 32253535, PMID 32333591, PMID 32491937, PMID 32690074, PMID 32835303, PMID 32990739, PMID 32991844, PMID 33001967, PMID 33225989, PMID 33320115

NIH funding

2023 (2), 2008 (1), 2016 (1), P30DK072488 (1), R01AG041795 (1), R01AT010896 (1), R01DC021179 (1), R01DC021422 (1), R21DC023711 (1), R21MH127479 (1), U01DC019579 (1), UM1TR004772 (1)